NEW YORK, Sept. 16, 2016 -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Orbital ATK, Inc. securities (NYSE:OA) from June 1, 2015 through August 9, 2016, both dates inclusive (the “Class Period”). The lawsuit seeks to recover damages for Orbital investors under the federal securities laws.
To join the Orbital class action, go to the firm’s website at http://www.rosenlegal.com/cases-932.html or call Phillip Kim, Esq. or Kevin Chan, Esq. toll free at 866-767-3653 or email [email protected] or [email protected] for more information on the class action.
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.
According to the lawsuit, throughout the Class Period defendants issued false and misleading statements to investors and/or failed to disclose that (1) Orbital lacked effective control over financial reporting; (2) Orbital failed to record an anticipated loss on a $2.3 billion long-term contract with the U.S. Army to manufacture and supply small caliber ammunition at the U.S. Army’s Lake City Army Ammunition Plant after the loss became evident in 2015, as required by generally accepted accounting principles; and (3) as a result, defendants’ statements about Orbital’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.
A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than October 11, 2016. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to the firm’s website at http://www.rosenlegal.com/cases-932.html for more information. You may also contact Phillip Kim, Esq. or Kevin Chan, Esq. of Rosen Law Firm toll free at 866-767-3653 or via email at [email protected] or [email protected].
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm.
Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. Kevin Chan, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 34th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 [email protected] [email protected] [email protected] www.rosenlegal.com


Amazon in Talks to Invest $10 Billion in OpenAI as AI Firm Eyes $1 Trillion IPO Valuation
Shell M&A Chief Exits After BP Takeover Proposal Rejected
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
Robinhood Expands Sports Event Contracts With Player Performance Wagers
Biren Technology Targets Hong Kong IPO to Raise $300 Million Amid China’s AI Chip Push
ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
Republicans Raise National Security Concerns Over Intel’s Testing of China-Linked Chipmaking Tools
MetaX IPO Soars as China’s AI Chip Stocks Ignite Investor Frenzy
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions
LG Energy Solution Shares Slide After Ford Cancels EV Battery Supply Deal
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease 



